You’ve viewed 1 of 5 articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.

The RAINIER Study (NCT06496607) is an ongoing Phase IIa clinical trial investigating Solrikitug for adults with asthma. This randomized, double-blind, placebo-controlled study evaluates three dose ...

We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other most ...

We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other ...

In other recent news, GSK plc announced that the US Food and Drug Administration has accepted the Biologics License Application for depemokimab, targeting asthma and chronic rhinosinusitis with nasal ...

In other recent news, GSK plc announced that the US Food and Drug Administration has accepted the Biologics License Application for depemokimab, targeting asthma and chronic rhinosinusitis with ...

Mepolizumab is additionally indicated for treating CRSwNP. Depemokimab, a novel treatment, differs from mepolizumab due to specific modifications in its amino acid sequence. These alterations enhance ...